DCGI
. New Delhi, Delhi, India
COVID India: Panel recommends emergency use for Corbevax in 12-18 age group
. Hyderabad, Telangana, India
Bharat Biotech’s intranasal COVID-19 booster doses get approval for trials
. New Delhi, Delhi, India
DCGI grants conditional market approval for Covishield, Covaxin
. New Delhi, Delhi, India
All you need to known about Hetero’s Tocilizumab for COVID-19
. Hyderabad, Telangana, India
Hetero’s Tocilizumab gets DCGI approval for COVID-19 treatment
. New Delhi, Delhi, India